Acute OxyContin withdrawal typically begins within six to ten hours of the last dose, peaks around the third or fourth day, and largely subsides within seven to ten days. That timeline, though, describes only the most intense physical symptoms. Lingering effects on sleep, mood, and pain sensitivity can stretch for weeks or even months, and the overall duration depends heavily on how much you were taking, for how long, and how the detox is managed.
When Withdrawal Starts
OxyContin is the extended-release formulation of oxycodone. Because the drug is designed to dissolve slowly and maintain steady blood levels over about twelve hours, the body does not notice the drug’s absence as quickly as it would with an immediate-release pill. The plasma half-life of controlled-release oxycodone is roughly twelve hours, compared to three to five hours for immediate-release versions.1PubMed. Oxycodone: a pharmacological and clinical review That distinction matters because the onset of withdrawal is loosely tied to how fast the drug clears your system.
Withdrawal signs generally appear within six to ten hours after the last dose of a short-acting opioid.2PubMed Central. Alleviating Symptoms of Withdrawal from an Opioid With OxyContin’s slower release, the window is often a bit later. Many people start feeling the first symptoms roughly twelve to twenty-four hours after their last tablet, though individual experiences vary. The early signs tend to be subtle at first: anxiety, restlessness, watery eyes, a runny nose, and yawning. They are easy to mistake for the beginnings of a cold, which sometimes delays recognition of what is actually happening.
The Acute Withdrawal Timeline
The first three days are usually the hardest. After the early restlessness and anxiety, physical symptoms intensify: muscle aches, sweating, chills, nausea, vomiting, diarrhea, and insomnia. Many people describe the combination as the worst flu they have ever had, multiplied. Heart rate goes up, blood pressure rises, and the gastrointestinal upset can be severe enough to cause dehydration if fluids are not replaced.
Peak intensity tends to fall between days two and four. By days five through seven, the worst of the physical symptoms begin to ease. Most people feel noticeably better by the end of the first week, and the acute physical withdrawal is broadly over within seven to ten days for the majority of OxyContin users. That does not mean you feel normal at day ten. Fatigue, poor sleep, and irritability often linger well past the acute window.
The timeline stretches if someone was taking very high doses or had been on OxyContin for years rather than months. The body accumulates deeper neurological adaptations the longer opioid exposure continues. Chronic opioid use triggers changes in the brain’s signaling pathways, particularly in regions that regulate arousal and stress. Neurons gradually adjust their firing rate and internal chemistry to compensate for the constant presence of the drug, so when that drug disappears, the rebound is proportionally larger.3PubMed Central. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction
Protracted Withdrawal and What Comes After the Acute Phase
One of the least discussed aspects of OxyContin detox is what happens after the textbook withdrawal period ends. Many people expect to feel recovered after the first week or two and are caught off guard when symptoms persist. Protracted withdrawal, sometimes called post-acute withdrawal syndrome, can include heightened sensitivity to pain, anxiety, depressed mood, trouble concentrating, and disturbed sleep that continues for weeks to months.
Animal research on oxycodone dependence offers a window into the biology of this prolonged phase. In a 2024 study, mice withdrawn from chronic oxycodone showed increased pain sensitivity that lasted roughly twenty-four days for pressure-related pain and about two weeks for cold sensitivity. Anxiety-like behaviors emerged two to three weeks after the drug was removed, even as the earlier physical signs of withdrawal had resolved.4PubMed Central. Characterization and validation of a spontaneous acute and protracted oxycodone withdrawal model in male and female mice These findings mirror what clinicians see in human patients: the physical flu-like symptoms fade, but mood and pain problems can crop up on a delayed schedule.
The mechanism behind this delayed rebound involves long-lasting changes to how neurons process signals. In brain regions such as the locus coeruleus, which plays a key role in arousal and stress, chronic opioid exposure drives the neurons to ramp up an internal signaling pathway to counterbalance the drug’s suppressive effects. While the drug is present, the system stays roughly in equilibrium. Once the drug is gone, that ramped-up pathway fires unchecked, producing heightened stress responses and hyperactivity that can outlast the drug’s physical clearance by a wide margin.5Cell Press (Neuron). Under Siege: The Brain on Opiates The practical takeaway is that feeling “off” for a month or more after your last OxyContin dose is not unusual and does not mean something is wrong with your recovery.
Why the Timeline Varies So Much from Person to Person
If you ask ten people who have been through OxyContin withdrawal how long it took, you will likely get ten different answers. Several factors explain the range.
- Dose and duration: Someone who took 40 mg daily for a few months will generally have a shorter, milder withdrawal than someone who escalated to 160 mg or more over several years. Higher and longer exposure means deeper neurological adaptation and a longer recovery arc.
- Metabolism: Oxycodone is processed in the liver primarily by two enzyme families. One pathway handles the bulk of clearance, while a second produces a more potent byproduct called oxymorphone.6Drug Metabolism and Disposition. Quantitative Contribution of CYP2D6 and CYP3A to Oxycodone Metabolism in Human Liver and Intestinal Microsomes Genetic differences in the enzymes that run these pathways can substantially change how quickly or slowly you clear the drug. People who metabolize oxycodone very quickly may experience a faster onset of withdrawal, while slow metabolizers might notice a more gradual but drawn-out course.
- Genetic variation in CYP2D6: The enzyme responsible for converting oxycodone into oxymorphone comes in several genetic variants. People who are “ultra-rapid metabolizers” produce significantly more oxymorphone, while “poor metabolizers” produce far less. Research has shown that oxymorphone levels can be more than 60 percent lower in poor metabolizers compared to the other groups, and drug interactions that block the relevant enzymes shift the balance further.7PubMed Central. The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone These differences affect not just the drug’s pain-relieving effect but also the intensity and timing of withdrawal.
- Other substances: Using OxyContin alongside benzodiazepines, alcohol, or other drugs complicates the withdrawal picture. Each substance has its own withdrawal syndrome, and they can overlap or interact unpredictably. The primary substance someone was misusing also influences how long inpatient detox takes and the likelihood of completing it.8SpringerLink / International Journal of Mental Health and Addiction. Psychiatric Comorbidities of Substance Use Disorders: Does Dual Diagnosis Predict Inpatient Detoxification Treatment Outcomes?
- Mental health: Depression, anxiety disorders, and PTSD are extremely common among people with opioid dependence. The same study found that more than half of inpatient detox patients had documented depression. While psychiatric diagnoses did not significantly predict whether someone completed detox, medication non-compliance did, suggesting that managing mental health conditions during and after withdrawal is important for staying the course.
Medical Approaches to Managing Detox
Detoxing from OxyContin without medical support is physically safe for most otherwise-healthy adults, but the discomfort is severe enough that many people relapse within the first few days simply to make the symptoms stop. Medical detox does not necessarily shorten the timeline, but it makes the process far more survivable.
The most effective approach, according to decades of clinical evidence, involves substituting OxyContin with a longer-acting opioid such as methadone or buprenorphine and then gradually tapering the substitute down to zero.9PubMed Central. Pharmacologic treatments for opioid dependence: detoxification and maintenance options Both medications activate the same brain receptors as oxycodone but do so more gently and with a longer half-life, which smooths out the withdrawal curve. A Cochrane review found that buprenorphine and methadone have a similar ability to ease opioid withdrawal without clinically significant side effects.10PubMed Central. Buprenorphine for the management of opioid withdrawal
The taper duration varies. A rapid taper might last five to seven days in an inpatient setting. A slow outpatient taper could stretch over thirty days or more, particularly when the starting dose of OxyContin was high and the smallest available tablet is 10 mg. Cutting a controlled-release tablet in half defeats the extended-release mechanism, so dose reductions tend to happen in coarser steps than would be ideal.2PubMed Central. Alleviating Symptoms of Withdrawal from an Opioid Switching to buprenorphine or methadone allows finer dose adjustments and a gentler descent.
For people who cannot or prefer not to use an opioid substitute, alpha-2 adrenergic agonists such as clonidine and lofexidine are another option. These medications do not activate opioid receptors at all. Instead, they dampen the overactive stress response that causes many of the physical withdrawal symptoms. Cochrane evidence shows that these drugs roughly doubled the likelihood of completing treatment compared with placebo and cut the chance of severe withdrawal by about two-thirds.11Cochrane Database of Systematic Reviews. Clonidine, lofexidine, and similar medications for the management of opioid withdrawal In head-to-head comparison, lofexidine caused fewer issues with low blood pressure and sedation than clonidine, along with lower overall withdrawal scores.12PubMed. Lofexidine versus clonidine in rapid opiate detoxification Lofexidine is the only alpha-2 agonist specifically approved in the United States for managing opioid withdrawal symptoms.13PubMed Central. A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms
In practice, most medically supervised detox programs combine approaches: a short opioid taper for the first few days, supplemented with clonidine or lofexidine for autonomic symptoms, plus medications for sleep, nausea, and diarrhea as needed. The total supervised detox period, from first day to the point where you are off all opioids, typically runs five to fourteen days in an inpatient setting, depending on the taper speed and how your body responds.
The Overlooked Danger After Detox
Here is an uncomfortable reality that is not discussed enough: completing detox can be more dangerous than being in the middle of it. Once you have gone through withdrawal, your opioid tolerance drops dramatically. A dose that was routine for you a few weeks ago can now be lethal if you relapse.
A follow-up study of patients who completed inpatient opioid detoxification illustrates this starkly. Researchers tracked 137 patients and grouped them by how much tolerance they had lost by the time they left treatment. The three overdose deaths that occurred within four months all happened in the group that had fully completed the detoxification program and lost the most tolerance. No overdose deaths occurred in the group that left treatment early while still partially tolerant.14BMJ. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study The finding is counterintuitive: the patients who “succeeded” at detox faced the highest overdose risk, precisely because their bodies could no longer handle the dose they were used to taking.
This is why aftercare planning is considered just as important as the detox itself. Simply getting through withdrawal does not address the underlying dependence. Most clinical guidelines now recommend transitioning directly from detox into longer-term treatment, which might mean maintenance medication (buprenorphine or methadone continued at a stable dose rather than tapered to zero), behavioral therapy, or both. One year follow-up data on patients who continued buprenorphine-naloxone maintenance or injectable nalmefene after completing their initial detoxification phase shows that longer treatment retention is associated with better outcomes, reinforcing the idea that detox is a beginning, not an endpoint.15Psychiatry Research. One year follow-up study of patients with opioid use disorder after inpatient detoxification: Predictors of treatment retention and abstinence
Detox During Pregnancy
Opioid detox during pregnancy is one of the most debated areas in addiction medicine. For decades, the standard advice was to avoid detox entirely and maintain pregnant patients on methadone, because abrupt withdrawal can trigger preterm labor or fetal distress. More recent evidence suggests that carefully managed detox is feasible for some patients, though it requires close monitoring.
In one study of 34 pregnant women who elected to undergo opioid detoxification, the median time to complete detox was twelve days, though the range was wide, spanning from three to thirty-nine days. About 59 percent of the women successfully completed the process and did not relapse during the remainder of their pregnancy, while roughly 29 percent resumed opioid use and 12 percent opted to switch to methadone maintenance instead of continuing the taper.16PubMed. Opioid detoxification in pregnancy The results suggest detox is possible in a supervised setting during the second trimester and beyond, but the relapse rate underscores why maintenance treatment remains the default recommendation for most pregnant patients.
The methadone doses used were modest compared to typical maintenance doses, with a median maximum of 20 mg per day. The gradual taper, combined with close fetal monitoring, helped manage the risk. Anyone considering opioid detox during pregnancy should be doing so under direct medical supervision, as the stakes involve two patients rather than one.
How Withdrawal Severity Is Measured in a Clinical Setting
If you go through a medically supervised detox, the staff will likely use a standardized scoring tool called the Clinical Opiate Withdrawal Scale, or COWS, to track how you are doing. The tool assigns points based on observable signs like pulse rate, sweating, pupil size, tremor, yawning, and gastrointestinal distress, along with self-reported symptoms such as bone and joint aches and anxiety. The total score determines whether your withdrawal is classified as mild, moderate, moderately severe, or severe, which in turn guides medication dosing decisions.
The scoring is done repeatedly, sometimes every few hours in the first day or two, to catch the moment when withdrawal is intense enough to begin administering buprenorphine. Starting buprenorphine too early, before sufficient withdrawal has set in, can actually precipitate worse withdrawal symptoms due to the drug’s partial-agonist properties. So the COWS score serves as a practical gatekeeper: it tells the clinical team when the patient’s body is ready for the substitution medication. The scale has recently been translated into Spanish to improve communication in clinical settings where English is not the patient’s first language, reflecting the practical importance of accurate assessment.17Dove Medical Press / PubMed Central. Creating and Piloting a Spanish-Language Version of the Clinical Opiate Withdrawal Scale (COWS): La Escala Clínica de Síndrome Abstinencia de Opiáceos (ECAO)
For patients going through detox at home with a prescription taper, there are simplified self-assessment versions of similar scales, though their reliability is lower without a clinician checking objective signs. The key point is that withdrawal is not a binary state you are either in or out of. It is a spectrum, and tracking where you are on that spectrum helps determine the right medication timing and the right level of support.